Association of inflammation and protein-energy wasting with endothelial dysfunction in peritoneal dialysis patients

Nephrology Dialysis Transplantation

Volumn 25, Issue 4, 2010, Pages 1266-1271

  Choi, Hoon Young ^a   Lee, Jung Eun ^b   Han, Seung Hyeok ^c   Yoo, Tae Hyun ^a   Kim, Beom Seok ^a   Park, Hyeong Cheon ^a   Kang, Shin Wook ^a   Choi, Kyu Hun ^a   Ha, Sung Kyu ^a   Lee, Ho Yung ^a   Han, Dae Suk ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c National Health Insurance Corporation   (South Korea)

Author keywords

Endothelial dysfunction; Inflammation; Peritoneal dialysis; Protein energy wasting

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6;

ADULT; ARTICLE; BIOCHEMISTRY; BODY WEIGHT; CHRONIC INFLAMMATION; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; DOPPLER ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; ENERGY; FEMALE; HEMODIALYSIS PATIENT; HUMAN; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; MULTIPLE REGRESSION; NUTRITIONAL STATUS; PERITONEAL DIALYSIS; PRIORITY JOURNAL; RATING SCALE; SEX; VASODILATATION;

CROSS-SECTIONAL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PROTEIN-ENERGY MALNUTRITION; TREATMENT OUTCOME; VASODILATION;

EID: 77950248157     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp598     Document Type: Article

References (43)

1. Collins AJ, Foley RN, Herzog C, et al. United States Renal Data System 2008 Annual Data Report Abstract. Am J Kidney Dis 2009; 53: vi-viiS8-374
2. Zoccali C. Traditional and emerging cardiovascular and renal risk factors: an epidemiologic perspective. Kidney Int 2006; 70: 26-33
3. Fouque D, Kalantar-Zadeh K, Kopple J, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 2008; 73: 391-398
4. Fung F, Sherrard DJ, Gillen DL, et al. Increased risk for cardiovascular mortality among malnourished end-stage renal disease patients. Am J Kidney Dis 2002; 40: 307-314
5. Cooper BA, Penne EL, Bartlett LH, et al. Protein malnutrition and hypoalbuminemia as predictors of vascular events and mortality in ESRD. Am J Kidney Dis 2004; 43: 61-66
6. Stenvinkel P, Heimburger O, Paultre F, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999; 55: 1899-1911
7. Zimmermann J, Herrlinger S, Pruy A, et al. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999; 55: 648-658
8. Stenvinkel P, Heimburger O, Lindholm B, et al. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant 2000; 15: 953-960
9. Park JS, Kim SB. C-reactive protein as a cardiovascular risk factor and its therapeutic implications in end-stage renal disease patients. Nephrology (Carlton) 2003; 8: S40-S44
10. Landray MJ, Wheeler DC, Lip GY, et al. Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study. Am J Kidney Dis 2004; 43: 244-253
11. Rattazzi M, Puato M, Faggin E, et al. New markers of accelerated atherosclerosis in end-stage renal disease. J Nephrol 2003; 16: 11-20
12. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111-1115
13. McGorisk GM, Treasure CB. Endothelial dysfunction in coronary heart disease. Curr Opin Cardiol 1996; 11: 341-350
14. Glasser SP, Selwyn AP, Ganz P. Atherosclerosis: risk factors and the vascular endothelium. Am Heart J 1996; 131: 379-384
15. Verma S, Buchanan MR, Anderson TJ. Endothelial function testing as a biomarker of vascular disease. Circulation 2003; 108: 2054-2059
16. Ganz P, Vita JA. Testing endothelial vasomotor function: nitric oxide, a multipotent molecule. Circulation 2003; 108: 2049-2053
17. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004; 109: III27-III32
18. Katz SD, Hryniewicz K, Hriljac I, et al. Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure. Circulation 2005; 111: 310-314
19. Bolton CH, Downs LG, Victory JG, et al. Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokines. Nephrol Dial Transplant 2001; 16: 1189-1197
20. Stam F, van Guldener C, Becker A, et al. Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study. J Am Soc Nephrol 2006; 17: 537-545
21. van Guldener C, Lambert J, Janssen MJ, et al. Endothelium-depen-dent vasodilatation and distensibility of large arteries in chronic hae-modialysis patients. Nephrol Dial Transplant 1997; 12: 14-18
22. van Guldener C, Janssen MJ, Lambert J, et al. Endothelium-depen-dent vasodilatation is impaired in peritoneal dialysis patients. Nephrol Dial Transplant 1998; 13: 1782-1786
23. MalyszkoJ,MalyszkoJS,MysliwiecM.Endothelialcell injury markers in chronic renal failure on conservative treatment and continuous ambulatory peritoneal dialysis. Kidney Blood Press Res 2004; 27: 71-77
24. Papagianni A, Kokolina E, Kalovoulos M, et al. Carotid atherosclerosis is associated with inflammation, malnutrition and intercellular adhesion molecule-1 in patients on continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 2004; 19: 1258-1263
25. Suliman ME, Qureshi AR, Heimburger O, et al. Soluble adhesion molecules in end-stage renal disease: a predictor of outcome. Nephrol Dial Transplant 2006; 21: 1603-1610
26. Wang AY, Lam CW, Wang M, et al. Circulating soluble vascular cell adhesion molecule 1: relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients. Am J Kidney Dis 2005; 45: 715-729
27. Kang SM, Chung N, Kim JY, et al. Relation of vasodilator response of the brachial artery to inflammatory markers in patients with coronary artery disease. Echocardiography 2002; 19: 661-667
28. Garcia-Lopez E, Carrero JJ, Suliman ME, et al. Risk factors for cardiovascular disease in patients undergoing peritoneal dialysis. Perit Dial Int 2007; 27: S205-S209
29. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998; 9: S16-S23
30. Stenvinkel P. Malnutrition and chronic inflammation as risk factors for cardiovascular disease in chronic renal failure. Blood Purif 2001; 19: 143-151
31. Iiyama K, Nagano M, Yo Y, et al. Impaired endothelial function with essential hypertension assessed by ultrasonography. Am Heart J 1996; 132: 779-782
32. Panza JA, Quyyumi AA, Brush JE Jr, et al. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22-27
33. Celermajer DS, Sorensen KE, Spiegelhalter DJ, et al. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol 1994; 24: 471-476
34. Sorensen KE, Celermajer DS, Georgakopoulos D, et al. Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level. J Clin Invest 1994; 93: 50-55
35. Dogra G, Irish A, Chan D, et al. Insulin resistance, inflammation, and blood pressure determine vascular dysfunction in CKD. Am J Kidney Dis 2006; 48: 926-934
36. Kari JA, Donald AE, Vallance DT, et al. Physiology and biochemistry of endothelial function in children with chronic renal failure. Kidney Int 1997; 52: 468-472
37. Joannides R, Bakkali EH, Le Roy F, et al. Altered flow-dependent vasodilatation of conduit arteries in maintenance haemodialysis. Ne-phrol Dial Transplant 1997; 12: 2623-2628
38. Joannides R, Haefeli WE, Linder L, et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995; 91: 1314-1319
39. Hand MF, Haynes WG, Webb DJ. Hemodialysis and L-arginine, but not D-arginine, correct renal failure-associated endothelial dysfunction. Kidney Int 1998; 53: 1068-1077
40. Ramadan MM, Mahfouz EM, Gomaa GF, et al. Evaluation of coronary calcium score by multidetector computed tomography in relation to endothelial function and inflammatory markers in asymptomatic individuals. Circ J 2008; 72: 778-785
41. Caglar K, Yilmaz MI, Saglam M, et al. Serum fetuin-a concentration and endothelial dysfunction in chronic kidney disease. Nephron Clin Pract 2008; 108: c233-c240
42. Caglar K, Yilmaz MI, Saglam M, et al. Short-term treatment with se-velamer increases serum fetuin-a concentration and improves endo-thelial dysfunction in chronic kidney disease stage 4 patients. Clin J Am Soc Nephrol 2008; 3: 61-68
43. Zoccali C. The endothelium as a target in renal diseases. J Nephrol 2007; 20: S39-S44